Compare WTFC & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WTFC | HALO |
|---|---|---|
| Founded | 1991 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.5B | 7.4B |
| IPO Year | N/A | N/A |
| Metric | WTFC | HALO |
|---|---|---|
| Price | $143.12 | $68.77 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 12 |
| Target Price | ★ $154.67 | $73.33 |
| AVG Volume (30 Days) | 490.0K | ★ 2.3M |
| Earning Date | 01-20-2026 | 11-03-2025 |
| Dividend Yield | ★ 1.39% | N/A |
| EPS Growth | 13.95 | ★ 56.68 |
| EPS | ★ 10.89 | 4.74 |
| Revenue | ★ $2,563,182,000.00 | $1,242,852,000.00 |
| Revenue This Year | $17.85 | $34.83 |
| Revenue Next Year | $5.85 | $24.84 |
| P/E Ratio | ★ $13.20 | $14.44 |
| Revenue Growth | 13.69 | ★ 31.19 |
| 52 Week Low | $89.10 | $46.76 |
| 52 Week High | $144.70 | $79.50 |
| Indicator | WTFC | HALO |
|---|---|---|
| Relative Strength Index (RSI) | 64.99 | 58.75 |
| Support Level | $142.44 | $61.23 |
| Resistance Level | $144.70 | $69.28 |
| Average True Range (ATR) | 2.36 | 1.69 |
| MACD | 0.09 | 0.69 |
| Stochastic Oscillator | 83.60 | 93.54 |
Wintrust Financial Corp is a financial holding company that provides community-oriented, personal, and commercial banking services to customers generally located in the Chicago metropolitan area, southern Wisconsin, northwest Indiana, and western Michigan. The company provides specialty finance services, including financing for the payment of property and casualty insurance premiums and life insurance premiums, and wealth management services to customers in its market area. The company's operations consist of three primary segments: community banking, specialty finance, and wealth management. The company generates the majority of its revenue from the community banking segment.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.